Providing market intelligence for more than 35 years

In The News

DIY Cameras Account for Majority of Smart Home IP Camera Sales in the U.S.

Research firm Parks Associates estimates Verizon Communications, AT&T, T-Mobile, and Sprint were all found to have throttled the speeds of mobile video content, with an estimated $889 million in revenues.

“IP cameras are key security-related devices and provide peace of mind to consumers. As such, these devices are consistently among the most popular smart home devices,” says Dina Abdelrazik, research analyst, Parks Associates. “Currently 9% of U.S. broadband households own one, but advances in image recognition and ease of self-installation, combined with a strong user experience, are driving increased adoption, with retail channels (online and in-store) starting to dominate sales.”

From the article "DIY Cameras Account for Majority of Smart Home IP Camera Sales in the U.S."  
 

Previously In The News

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

The future of mobile payments – are there too many options that are confusing consumers and merchants?

“Merchants are still slowly upgrading their retail point of sale (POS) systems to support various mobile payment options while new payment options keep showing up. No merchants have provided a complet...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...